CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity.
Liu C, Shen M, Liu Y, Manhas A, Zhao SR, Zhang M, Belbachir N, Ren L, Zhang JZ, Caudal A, Nishiga M, Thomas D, Zhang A, Yang H, Zhou Y, Ameen M, Sayed N, Rhee JW, Qi LS, Wu JC.
Liu C, et al. Among authors: wu jc.
Cell Stem Cell. 2024 Nov 7:S1934-5909(24)00369-2. doi: 10.1016/j.stem.2024.10.007. Online ahead of print.
Cell Stem Cell. 2024.
PMID: 39515331